Trials / Completed
CompletedNCT01803568
Skeletal Muscles, Myokines and Glucose Metabolism MYOGLU
Skeletal Muscles, Myokines and Glucose Metabolism
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- Male
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Normal glucose uptake and metabolism in skeletal muscles are essential to keep blood glucose within normal range and hence, insulin resistance (possibly mediated by inflammatory processes) in skeletal muscle is a major pathogenic factor in type 2 diabetes. Physical activity seems to be of essential importance in the prevention and treatment of type 2 diabetes. Myokines are proteins secreted from skeletal muscle that can execute important biological functions locally in the muscle (paracrine) or in other organs like the brain, heart and pancreas (endocrine). Evidence suggest that several interleukines and other cytokines are secreted by skeletal muscles. In the present project, the investigators will explore the relation between secreted myokines from muscle cells, insulin resistance and glucose metabolism before and after 12 weeks of exercise intervention. Subjects with normal as well as impaired glucose metabolism will be included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise | 12 weeks of exercise; 4 times pr week |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2013-03-04
- Last updated
- 2013-03-04
Source: ClinicalTrials.gov record NCT01803568. Inclusion in this directory is not an endorsement.